1. Vorinostat enhances the anticancer effect of oxaliplatin on hepatocellular carcinoma cells
   Bo Liao et al, 2017, Cancer Med CrossRef
2. Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV
   M. A. Rochat et al, 2017, J. Virol. CrossRef
3. Synergistic suppressive effect of PARP-1 inhibitor PJ34 and HDAC inhibitor SAHA on proliferation of liver cancer cells
   Bin-yong Liang et al, 2015, J. Huazhong Univ. Sci. Technol. [Med. Sci.] CrossRef
4. New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics
   Yong-Tao Duan et al, 2019, CTMC CrossRef
5. The in vitro and vivo anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) and MG132 on the aggressive phenotypes of gastric cancer cells
   Hang Lu et al, 2016, Oncotarget CrossRef
6. Epigenetic actions of environmental factors and promising drugs for cancer therapy (Review)
   Zhong‑Tian Bai et al, 2017, Oncol Lett CrossRef
7. Microbiota and epigenetics: promising therapeutic approaches?
   Amr El-Sayed et al, 2021, Environ Sci Pollut Res CrossRef
8. Histone Deacetylase Functions in Gastric Cancer: Therapeutic Target?
   Amandine Badie et al, 2022, Cancers CrossRef
9. Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?
   Viviana Brembati et al, 2023, Front. Mol. Neurosci. CrossRef